IL13RA2 and central nervous system cancer: CAR‐T cells were exposed to three different concentrations of recombinant IL‐13Rα2Fc chimeric protein or conditioned medium obtained from IL‐13Rα2 positive (U251) and IL‐13Rα2 negative (T98G) human glioma cell lines.